Intelligence as a Service
Alzheimer's disease (AD) is an irreversible, progressive brain disorder that destroys memory and cognitive functions. The fast growth of the graying population is a worldwide problem. Globally 44 million people have AD with a life expectancy of 4-8 years, and the number will triple by 2050. Currently there is no treatment nor proper diagnosis. Scientists have raised concerns with disproportionately low funding that slows development of treatments. We should explore ways for developing more efficiently with limited resources; we need a platform for scientists, doctors and general public to share reliable scientific findings and to seek solutions for their problems. Our team uses artificial intelligence to discover useful insights into AD; we use predictive models for novel drugs and machine learning to fill in knowledge gaps and new discoveries. We provide consulting, algorithmic solutions & ex vivo validation to find a better way of diagnosing & treating AD for people's better life.